• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与年龄相关的炎症性骨髓微环境诱导无效性红细胞生成,类似于 del(5q) MDS。

Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.

机构信息

Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Cancer Biology PhD Program, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida, Tampa, FL, USA.

出版信息

Leukemia. 2018 Apr;32(4):1023-1033. doi: 10.1038/leu.2017.326. Epub 2017 Nov 16.

DOI:10.1038/leu.2017.326
PMID:29263441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5886057/
Abstract

Anemia is characteristic of myelodysplastic syndromes (MDS). The mechanisms of anemia in MDS are unclear. Using a mouse genetic approach, here we show that dual deficiency of mDia1 and miR-146a, encoded on chromosome 5q and commonly deleted in MDS (del(5q) MDS), causes an age-related anemia and ineffective erythropoiesis mimicking human MDS. We demonstrate that the ageing bone marrow microenvironment is important for the development of ineffective erythropoiesis in these mice. Damage-associated molecular pattern molecules (DAMPs), whose levels increase in ageing bone marrow, induced TNFα and IL-6 upregulation in myeloid-derived suppressor cells (MDSCs) in mDia1/miR-146a double knockout mice. Mechanistically, we reveal that pathologic levels of TNFα and IL-6 inhibit erythroid colony formation and differentially affect terminal erythropoiesis through reactive oxygen species-induced caspase-3 activation and apoptosis. Treatment of the mDia1/miR-146a double knockout mice with all-trans retinoic acid, which promoted the differentiation of MDSCs and ameliorated the inflammatory bone marrow microenvironment, significantly rescued anemia and ineffective erythropoiesis. Our study underscores the dual roles of the ageing microenvironment and genetic abnormalities in the pathogenesis of ineffective erythropoiesis in del(5q) MDS.

摘要

骨髓增生异常综合征(MDS)的特征是贫血。MDS 贫血的机制尚不清楚。我们采用小鼠遗传方法,在此表明,位于 5q 染色体上且在 MDS 中常见缺失的 mDia1 和 miR-146a 的双重缺失(del(5q) MDS)会导致与人类 MDS 相似的年龄相关性贫血和无效造血。我们证明,老化的骨髓微环境对于这些小鼠无效造血的发展很重要。在 mDia1/miR-146a 双敲除小鼠中,衰老骨髓中增加的损伤相关分子模式分子(DAMPs)诱导髓系来源的抑制细胞(MDSC)中 TNFα 和 IL-6 的上调。在机制上,我们揭示病理性 TNFα 和 IL-6 水平通过活性氧诱导的半胱天冬酶-3 激活和凋亡抑制红系集落形成并通过影响终末红细胞生成而产生差异影响。用全反式视黄酸治疗 mDia1/miR-146a 双敲除小鼠,可促进 MDSC 的分化并改善炎症性骨髓微环境,显著改善贫血和无效造血。我们的研究强调了衰老微环境和遗传异常在 del(5q) MDS 无效造血发病机制中的双重作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/79b107c53bf9/leu2017326f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/5a63ae31223f/leu2017326f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/ad667d63b284/leu2017326f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/c4ca6fb9bf75/leu2017326f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/4411676b4f1c/leu2017326f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/05cdf9af77aa/leu2017326f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/79b107c53bf9/leu2017326f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/5a63ae31223f/leu2017326f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/ad667d63b284/leu2017326f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/c4ca6fb9bf75/leu2017326f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/4411676b4f1c/leu2017326f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/05cdf9af77aa/leu2017326f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a085/5886057/79b107c53bf9/leu2017326f6.jpg

相似文献

1
Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.与年龄相关的炎症性骨髓微环境诱导无效性红细胞生成,类似于 del(5q) MDS。
Leukemia. 2018 Apr;32(4):1023-1033. doi: 10.1038/leu.2017.326. Epub 2017 Nov 16.
2
Dyserythropoiesis of myelodysplastic syndromes.骨髓增生异常综合征的异常红细胞生成
Curr Opin Hematol. 2017 May;24(3):191-197. doi: 10.1097/MOH.0000000000000325.
3
Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS.粒细胞上CD14的异常过表达使mDia1杂合性del(5q)骨髓增生异常综合征的先天免疫反应敏感化。
Blood. 2014 Jul 31;124(5):780-90. doi: 10.1182/blood-2014-01-552463. Epub 2014 Jun 2.
4
Deletion 5q MDS: molecular and therapeutic implications.5q 缺失 MDS 的分子与治疗学意义。
Best Pract Res Clin Haematol. 2013 Dec;26(4):365-75. doi: 10.1016/j.beha.2013.10.013. Epub 2013 Oct 16.
5
Lenalidomide: targeted anemia therapy for myelodysplastic syndromes.来那度胺:骨髓增生异常综合征的靶向性贫血治疗药物。
Cancer Control. 2006 Dec;13 Suppl:4-11. doi: 10.1177/107327480601304s02.
6
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.核糖体蛋白S14单倍体不足导致由S100A8和S100A9介导的红系分化受阻。
Nat Med. 2016 Mar;22(3):288-97. doi: 10.1038/nm.4047. Epub 2016 Feb 15.
7
Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.伴有5号染色体长臂间质性缺失的骨髓增生异常综合征的临床管理
J Clin Oncol. 2006 Jun 1;24(16):2576-82. doi: 10.1200/JCO.2005.03.6715.
8
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond.来那度胺:伴有5号染色体长臂缺失及其他情况的骨髓增生异常综合征。
Semin Hematol. 2017 Jul;54(3):159-166. doi: 10.1053/j.seminhematol.2017.06.003. Epub 2017 Jun 22.
9
Megakaryocytopoiesis in patients with myelodysplastic syndromes (MDS) with and without del(5q).伴有或不伴有5号染色体长臂缺失(del(5q))的骨髓增生异常综合征(MDS)患者的巨核细胞生成
Eur J Haematol. 1990 Aug;45(2):115-6. doi: 10.1111/j.1600-0609.1990.tb00431.x.
10
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.来那度胺可抑制恶性克隆,并上调定位于5q-综合征患者常见缺失区域的SPARC基因。
Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11406-11. doi: 10.1073/pnas.0610477104. Epub 2007 Jun 18.

引用本文的文献

1
DDX41 resolves G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death.DDX41 解开 G-四链体以维持红细胞基因组完整性并防止 cGAS 介导的细胞死亡。
Nat Commun. 2025 Aug 5;16(1):7195. doi: 10.1038/s41467-025-62307-7.
2
Non-essential role of S100A9 in hematopoiesis in primary MPN and MDS mouse models.S100A9在原发性骨髓增殖性肿瘤和骨髓增生异常综合征小鼠模型造血过程中的非必需作用
Cancer Biol Med. 2025 Jul 26;22(7):806-11. doi: 10.20892/j.issn.2095-3941.2025.0185.
3
Bone marrow microenvironment in myelodysplastic neoplasms: insights into pathogenesis, biomarkers, and therapeutic targets.

本文引用的文献

1
Dyserythropoiesis of myelodysplastic syndromes.骨髓增生异常综合征的异常红细胞生成
Curr Opin Hematol. 2017 May;24(3):191-197. doi: 10.1097/MOH.0000000000000325.
2
Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia.TRAF6介导的hnRNPA1泛素化将慢性固有免疫信号与骨髓增生异常联系起来。
Nat Immunol. 2017 Feb;18(2):236-245. doi: 10.1038/ni.3654. Epub 2016 Dec 26.
3
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype.NLRP3炎性小体作为骨髓增生异常综合征表型的驱动因素发挥作用。
骨髓增生异常综合征中的骨髓微环境:对发病机制、生物标志物及治疗靶点的见解
Cancer Cell Int. 2025 May 10;25(1):175. doi: 10.1186/s12935-025-03793-z.
4
PPIL2 is a target of the JAK2/STAT5 pathway and promotes myeloproliferation via degradation of p53.PPIL2是JAK2/STAT5信号通路的一个靶点,并通过降解p53促进骨髓增殖。
J Clin Invest. 2025 May 8;135(13). doi: 10.1172/JCI181394. eCollection 2025 Jul 1.
5
Premature ageing of lung alveoli and bone marrow cells from Terc deficient mice with different telomere lengths.来自不同端粒长度的Terc基因缺陷小鼠的肺泡和骨髓细胞过早衰老。
Sci Rep. 2025 Feb 19;15(1):6102. doi: 10.1038/s41598-025-90246-2.
6
Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment.用于自主造血和患者来源造血干细胞移植的诱导多能干细胞衍生的人骨髓类器官的开发。
Blood Adv. 2025 Jan 14;9(1):54-65. doi: 10.1182/bloodadvances.2024013361.
7
Neutrophil Diversity (Immature, Aged, and Low-Density Neutrophils) and Functional Plasticity: Possible Impacts of Iron Overload in β-Thalassemia.中性粒细胞多样性(未成熟、衰老和低密度中性粒细胞)和功能可塑性:β-地中海贫血中铁过载的可能影响。
Int J Mol Sci. 2024 Oct 3;25(19):10651. doi: 10.3390/ijms251910651.
8
Role of reactive oxygen species in myelodysplastic syndromes.活性氧在骨髓增生异常综合征中的作用。
Cell Mol Biol Lett. 2024 Apr 14;29(1):53. doi: 10.1186/s11658-024-00570-0.
9
mDia formins form hetero-oligomers and cooperatively maintain murine hematopoiesis.mDia 形成蛋白形成异型寡聚体,并协同维持小鼠造血。
PLoS Genet. 2023 Dec 29;19(12):e1011084. doi: 10.1371/journal.pgen.1011084. eCollection 2023 Dec.
10
ABIN1 (Q478) is Required to Prevent Hematopoietic Deficiencies through Regulating Type I IFNs Expression.ABIN1(Q478)通过调节 I 型干扰素的表达来防止造血缺陷。
Adv Sci (Weinh). 2024 Jan;11(3):e2303555. doi: 10.1002/advs.202303555. Epub 2023 Nov 27.
Blood. 2016 Dec 22;128(25):2960-2975. doi: 10.1182/blood-2016-07-730556. Epub 2016 Oct 13.
4
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas.全反式维甲酸减少骨髓来源抑制细胞可提高肉瘤嵌合抗原受体治疗效果。
Cancer Immunol Res. 2016 Oct;4(10):869-880. doi: 10.1158/2326-6066.CIR-15-0230. Epub 2016 Aug 22.
5
Bone Marrow Immunity and Myelodysplasia.骨髓免疫与骨髓增生异常综合征
Front Oncol. 2016 Jul 20;6:172. doi: 10.3389/fonc.2016.00172. eCollection 2016.
6
Erythropoietin-regulated oxidative stress negatively affects enucleation during terminal erythropoiesis.促红细胞生成素调节的氧化应激对终末红细胞生成过程中的去核产生负面影响。
Exp Hematol. 2016 Oct;44(10):975-81. doi: 10.1016/j.exphem.2016.06.249. Epub 2016 Jun 27.
7
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.核糖体蛋白S14单倍体不足导致由S100A8和S100A9介导的红系分化受阻。
Nat Med. 2016 Mar;22(3):288-97. doi: 10.1038/nm.4047. Epub 2016 Feb 15.
8
Autoimmune diseases and myelodysplastic syndromes.自身免疫性疾病和骨髓增生异常综合征。
Am J Hematol. 2016 May;91(5):E280-3. doi: 10.1002/ajh.24333. Epub 2016 Apr 4.
9
Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling.Tifab(一种5号染色体长臂缺失相关的骨髓增生异常综合征基因)的缺失通过解除Toll样受体-TRAF6信号通路的抑制来改变造血作用。
J Exp Med. 2015 Oct 19;212(11):1967-85. doi: 10.1084/jem.20141898. Epub 2015 Oct 12.
10
Recent Advances in the 5q- Syndrome.5q-综合征的最新进展
Mediterr J Hematol Infect Dis. 2015 May 20;7(1):e2015037. doi: 10.4084/MJHID.2015.037. eCollection 2015.